-+ 0.00%
-+ 0.00%
-+ 0.00%

Vivos Therapeutics plans SEC registration filing for proposed transferable rights offering

PUBT·06/11/2026 12:31:47
Listen to the news
Vivos Therapeutics plans SEC registration filing for proposed transferable rights offering
  • Vivos Therapeutics plans to file an SEC registration statement for a rights offering that would distribute transferable subscription rights as a shareholder dividend.
  • Record date targeted for the 30th day after SEC effectiveness; timing hinges on SEC review.
  • Each right expected to buy 1 share at the greater of USD 1.25 or 20% above the prior-day market price.
  • Rights expected to be exchange-listed, tradeable, exercisable for 9 months.
  • Exercise expected to trigger a similar 9-month subsequent right priced at the greater of USD 1.75 or 40% above the prior-day market price.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivos Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606110830PRIMZONEFULLFEED9745524) on June 11, 2026, and is solely responsible for the information contained therein.